Sever Pharma Solutions
Di Zhang is a highly experienced scientist with a robust background in pharmaceutical development and nanotechnology. Currently serving as a Project Responsible and Senior Scientist at Sever Pharma Solutions since March 2019, Di Zhang has previously held senior roles at AstraZeneca, contributing to the advancement of drug particle modification for inhalation applications. Academic contributions include significant research at the Suzhou Institute of Nano-Tech and Nano-Bionics and Åbo Akademi University, where Di Zhang focused on coordinating international research collaborations. With a Ph.D. in Biomaterials from Åbo Akademi University and extensive experience in scientific consulting, Di Zhang has demonstrated expertise in research project implementation, communication with industry partners, and publication in international scientific forums.
Sever Pharma Solutions
Sever Pharma Solutions brings your pharmaceutical ideas to life by offering expertise in high potent drug development, a drive to enhance performance, a passion for perfection, and a commitment to be your partner through the whole journey. We add value through the entire development and manufacturing processes with in-depth analytics, expertise in high potent drugs and polymer-based drug delivery systems, comprehensive material options, and creative solutions. By providing a complete value chain, from development to sourcing and worldwide commercial supply, we can offer you an optimized end-to-end solution. And as a committed long-term partner with a strong focus on creating a commercial product, we put all our resources at work for you to the finishing line – and beyond. Together with our global GMP compliance, regulatory services, and market access strategies, we can secure that your products will benefit patients all over the world.